Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders
A Comparison of Spot Test (Urine Protein/Creatinine Ratio) With 24 - Hour Urine Protein Excretion in Woman With Hypertensive Disorders of Pregnancy
1 other identifier
interventional
420
1 country
1
Brief Summary
The presence of proteinuria (\>300 mg/d) represents an important factor in the diagnosis and evaluation of the pregnant patient with an hypertensive disorder. The 24 hour collection of urine for proteinuria is the gold standard for the diagnosis of the condition and allows the physician to determine if an hypertensive disorder is related directly or not to the gestation. The problem is the time it takes and the technical difficulties related to the sample collection. An alternative is the quantification of protein and creatinine in a random sample of urine. We seek to evaluate if this method is as affective as the gold standard in the diagnosis of proteinuria (\>300 mg/d).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2012
CompletedFirst Posted
Study publicly available on registry
January 11, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedJanuary 4, 2018
January 1, 2018
4.3 years
January 8, 2012
January 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity and Specificity
The number of patients with a 24 hour urine collection with a proteinuria \> 300mg will be compared with the number of patients with a Spot Test (protein/creatinine ratio in a random urine sample) \> 0.2 (equivalent to the 24 hour test \> 300 mg). This value will be used to calculate the Sensitivity and Specificity of the spot test.
Six months
Secondary Outcomes (1)
Positive and Negative Predictive Value
six months
Study Arms (1)
Hypertensive disorder of pregnancy
OTHERPatients with an hypertensive disorder of pregnancy (28 weeks or more of gestation)will collect a random sample of urine for a spot test (protein/creatinine ratio) and urine for 24 hours. The level of proteinuria will be determined in this sample.
Interventions
Collection of a random sample of urine for a spot test and a 24 hour urine collection for a 24 hour urine protein.
Eligibility Criteria
You may qualify if:
- Pregnant women with 28 weeks or more of gestation.
- Complete collection of the 24 hour urine sample.
You may not qualify if:
- Failure to recollect the 24 hour urine sample.
- Pregestational Diabetes
- Kidney disease
- hour urine protein \> 8.0 g/dL or seric creatinine \> 2.0 mg/dL (it could indicate kidney disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Thomas H
Panama City, Panama
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osvaldo A Reyes, MD
Saint Thomas Hospital, Panama
- PRINCIPAL INVESTIGATOR
Joanna Buitrago, MD
Saint Thomas Hospital, Panama
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinator of Research & Development
Study Record Dates
First Submitted
January 8, 2012
First Posted
January 11, 2012
Study Start
March 1, 2012
Primary Completion
June 1, 2016
Study Completion
July 1, 2016
Last Updated
January 4, 2018
Record last verified: 2018-01